Bliss Gvs Pharma Limited (IN:BLISSGVS)
:BLISSGVS
Want to see IN:BLISSGVS full AI Analyst Report?
BLISSGVS Stock Chart & Stats
₹144.75
-₹6.85(-3.92%)
At close: 4:00 PM EST
₹144.75
-₹6.85(-3.92%)
Day’s Range― - ―
52-Week Range₹118.35 - ₹296.85
Previous CloseN/A
Volume571.01K
Average Volume (3M)104.36K
Market Cap
₹30.73B
Enterprise Value₹29.25B
Total Cash (Recent Filing)₹2.01B
Total Debt (Recent Filing)₹524.91M
Price to Earnings (P/E)18.6
Beta1.29
Next Earnings
Aug 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.28%
Share Statistics
EPS (TTM)10.40
Shares Outstanding105,788,970
10 Day Avg. Volume77,644
30 Day Avg. Volume104,358
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)1.20
Price to Sales (P/S)1.56
P/FCF Ratio42.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetA high equity ratio and low leverage give the company durable financial flexibility: supports working-capital needs, funds regulatory or manufacturing investments, and cushions earnings volatility in generics and export markets, enabling longer-term strategic moves.
Improving Profitability And MarginsImproving gross, net, EBIT and EBITDA margins reflect sustained cost controls and operational efficiency. That margin expansion increases reinvestable cash, supports competitiveness in pricing-sensitive segments, and strengthens the firm’s ability to fund growth or absorb margin pressure.
Diversified Formulation Revenue StreamsEarning from domestic branded sales, exports and contract manufacturing diversifies revenue and reduces single-market concentration. Multiple channels and B2B manufacturing relationships provide steady demand sources and make revenue less dependent on one product or geography.
Bears Say
Variable Free Cash FlowInconsistent free cash flow growth limits the company’s ability to consistently fund capex, repay obligations, or return capital. Over time this variability can restrain strategic investments, slow scale-up of exports or capacity, and require more careful working-capital management.
Modest Revenue GrowthRevenue growth near mid-single digits suggests gradual expansion rather than rapid scaling. In a competitive generics/formulations market, modest top-line growth can limit absolute margin gains and reduce ability to spread fixed costs, making long-term market-share gains harder.
Exposure To Generic Pricing PressureReliance on finished-dosage formulations and generic channels exposes the firm to structural price competition and distributor bargaining. Persistent pricing pressure or weaker partner terms can compress margins and constrain profitability despite operational improvements.
Bliss Gvs Pharma Limited News
BLISSGVS FAQ
What was Bliss Gvs Pharma Limited’s price range in the past 12 months?
Bliss Gvs Pharma Limited lowest stock price was ₹118.35 and its highest was ₹296.85 in the past 12 months.
What is Bliss Gvs Pharma Limited’s market cap?
Bliss Gvs Pharma Limited’s market cap is ₹30.73B.
When is Bliss Gvs Pharma Limited’s upcoming earnings report date?
Bliss Gvs Pharma Limited’s upcoming earnings report date is Aug 04, 2026 which is in 75 days.
How were Bliss Gvs Pharma Limited’s earnings last quarter?
Currently, no data Available
Is Bliss Gvs Pharma Limited overvalued?
According to Wall Street analysts Bliss Gvs Pharma Limited’s price is currently Overvalued.
Does Bliss Gvs Pharma Limited pay dividends?
Bliss Gvs Pharma Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.28%. See more information on Bliss Gvs Pharma Limited dividends here
What is Bliss Gvs Pharma Limited’s EPS estimate?
Bliss Gvs Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bliss Gvs Pharma Limited have?
Bliss Gvs Pharma Limited has 105,788,970 shares outstanding.
What happened to Bliss Gvs Pharma Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bliss Gvs Pharma Limited?
Currently, no hedge funds are holding shares in IN:BLISSGVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bliss Gvs Pharma Limited
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Technical Analysis
Bajaj Healthcare Ltd
―
Hester Biosciences Limited
―
Jagsonpal Pharmaceuticals Ltd.
―
Syncom Formulation (India) Ltd.
―
Windlas Biotech Ltd.
―